Other languages Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Market Closed - Nasdaq Other stock markets 21:30:00 03/05/2024 BST			5-day change	1st Jan Change
65.27 ^USD	+1.45%		-0.11%	-21.82%

04-26	Cytokinetics Appoints Sung Lee as CFO	MT
04-26	Cytokinetics, Incorporated Appoints Sung H. Lee as Executive Vice President, Effective as of May 8, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytokinetics Appoints Sung Lee as CFO	04-26
Cytokinetics, Incorporated Appoints Sung H. Lee as Executive Vice President, Effective as of May 8, 2024	04-26
Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing	04-09
Sector Update: Health Care Stocks Rise Friday Afternoon	04-05
Cytokinetics Reports Positive Follow-On Data for Prospective Heart Medication; Shares Rise	04-05
Cytokinetics Presents Additional 48-Week Data from Forest-Hcm, the Open Label Extension Clinical Study of Aficamten, At the American College of Cardiology 73rd Annual Scientific Session	04-05
Cytokinetics Q4 Net Loss Narrows, Revenue Decreases; 2024 Outlook Issued	02-27
Cytokinetics, Incorporated Provides Revenue Guidance for 2024	02-27
Cytokinetics, Incorporated Reports Earnings Results for the Full Year Ended December 31, 2023	02-27
Cytokinetics, Incorporated Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-27
Cytokinetics Insider Sold Shares Worth $960,625, According to a Recent SEC Filing	02-13
Cytokinetics Insider Sold Shares Worth $2,585,497, According to a Recent SEC Filing	02-06
Cytokinetics Insider Sold Shares Worth $994,625, According to a Recent SEC Filing	02-02
Cytokinetics, Incorporated Announces Resignation of Ching W. Jaw, Senior Vice President, Effective February 23, 2024	02-02
Cytokinetics Reports 'Favorable Effects' of Aficamten in Hypertrophic Cardiomyopathy Trial	01-25
Cytokinetics Insider Sold Shares Worth $425,700, According to a Recent SEC Filing	01-12
Insider - Novartis bläst mögliche Übernahme von Cytokinetics ab	01-12
Inflation, déflation, tensions	01-12
En Direct des Marchés : Airbus, Vinci, Casino, Burberry, Microsoft, Tesla, Novartis...	01-12
EN DIRECTO DESDE LOS MERCADOS: Airbus, Morgan Stanley, Novartis, Stellantis, Burberry, Microsoft, Tesla, Hugo Boss...	01-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Other languages

Filters